glp-1 and mcas GLP-1: Genetic Variants Related to RA Medications GLP-1 for MCAS: Addressing Gastroparesis

, ,

When it comes to the split between injectables and orals for GLP-1s, Stevanato said that injectables will remain the majority at approximately 70% while orals will be in the range of about 30%

Effects can last 612 hours

Incorrect injection can cause pain, bruising, or swelling

Known side effects include: Nausea, diarrhoea or constipation Loss of appetite, heartburn or bloating Rare but serious complications such as pancreatitis It is also unclear how long-term use over many years affects the body

Central to our approach are weekly GLP-1 injections which have been clinically proven to aid in weight management